​

Funding Round

Series B - Proacta

Series B - Proacta

Investment Firm

Overview

Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated “prodrugs” for the treatment of cancer.

Announced Date

Feb 07, 2007

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Clarus Ventures

Clarus Ventures

Clarus Ventures is a early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

8

Investor Name
Participant InvestorAlta Partners
Participant InvestorGenentech
Participant InvestorGBS Ventures
Participant InvestorDelphi Ventures
Participant InvestorRoche

Round Details and Background

Proacta raised $35000000 on 2007-02-07 in Series B

Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated “prodrugs” for the treatment of cancer.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 26, 2004
Series A - Proacta
2-1.5M
Feb 07, 2007
Series B - Proacta
8-35.0M
Feb 17, 2010
Debt Financing - Proacta
-3.0M
Dec 15, 2011
Debt Financing - Proacta
-500.0K

Recent Activity

There is no recent news or activity for this profile.